Cadila falls on earnings, broker downgrades
MUMBAI (Reuters) - Cadila Healthcare (CADI.NS) shares fell as much as 8.9 percent after October-December earnings disappointed on Friday, followed by broker downgrades.
Cadila said its December quarter net profit fell by 30.9 percent to 1.03 billion rupees.
Credit Suisse downgraded the stock to "neutral" from "outperform", citing delay in contribution from higher margin products.
(Reporting by Abhishek Vishnoi; Editing by Jijo Jacob)
- Tweet this
- Share this
- Digg this
A pick-up in retail inflation to its fastest pace on record will likely force Reserve Bank of India chief Raghuram Rajan to raise interest rates for a third time on Wednesday, crimping growth prospects for an already fragile economy. Full Article
Asia-Pacific M&A volume falls for third consecutive year, deal size grows. Full Article